Scientific Reports (Nov 2023)
Author Correction: JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disorders
- Geza Ambrus-Aikelin,
- Katsuyuki Takeda,
- Anthony Joetham,
- Milos Lazic,
- Davide Povero,
- Angelina M. Santini,
- Rama Pranadinata,
- Casey D. Johnson,
- Matthew D. McGeough,
- Federico C. Beasley,
- Ryan Stansfield,
- Christopher McBride,
- Lynnie Trzoss,
- Hal M. Hoffman,
- Ariel E. Feldstein,
- Jeffrey A. Stafford,
- James M. Veal,
- Gretchen Bain,
- Erwin W. Gelfand
Affiliations
- Geza Ambrus-Aikelin
- Jecure Therapeutics
- Katsuyuki Takeda
- Department of Pediatrics, National Jewish Health
- Anthony Joetham
- Department of Pediatrics, National Jewish Health
- Milos Lazic
- Jecure Therapeutics
- Davide Povero
- Jecure Therapeutics
- Angelina M. Santini
- Jecure Therapeutics
- Rama Pranadinata
- Jecure Therapeutics
- Casey D. Johnson
- Department of Pediatrics, University of California San Diego
- Matthew D. McGeough
- Department of Pediatrics, University of California San Diego
- Federico C. Beasley
- Jecure Therapeutics
- Ryan Stansfield
- Jecure Therapeutics
- Christopher McBride
- Jecure Therapeutics
- Lynnie Trzoss
- Jecure Therapeutics
- Hal M. Hoffman
- Department of Pediatrics, University of California San Diego
- Ariel E. Feldstein
- Department of Pediatrics, University of California San Diego
- Jeffrey A. Stafford
- Jecure Therapeutics
- James M. Veal
- Jecure Therapeutics
- Gretchen Bain
- Jecure Therapeutics
- Erwin W. Gelfand
- Department of Pediatrics, National Jewish Health
- DOI
- https://doi.org/10.1038/s41598-023-47251-0
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 1
Abstract
No abstracts available.
